NYSEMKT: HLSQTessera Defense & Homeland Security Inc Stock Ownership - Who owns Tessera Defense & Homeland Security?
Insider buying vs selling
Have Tessera Defense & Homeland Security Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Reuven Yeganeh | Director | 2026-03-17 | 530,000 | $2.00 | $1.06MBuy |
| Reuven Yeganeh | Director | 2026-03-17 | 530,000 | $5.00 | $2.65MSell |
| Reuven Yeganeh | Director | 2026-03-16 | 450,000 | $2.00 | $900.00kBuy |
| Reuven Yeganeh | Director | 2026-03-16 | 450,000 | $5.00 | $2.25MSell |
| Reuven Yeganeh | Director | 2026-03-13 | 370,000 | $2.00 | $740.00kBuy |
| Reuven Yeganeh | Director | 2026-03-13 | 370,000 | $5.00 | $1.85MSell |
| Reuven Yeganeh | Director | 2026-03-12 | 300,000 | $5.00 | $1.50MSell |
| Reuven Yeganeh | Director | 2026-03-11 | 300,000 | $2.00 | $600.00kSell |
HLSQ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HLSQ insiders and whales buy or sell their stock.
HLSQ Shareholders
What type of owners hold Tessera Defense & Homeland Security Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Orbimed Israel Biofund GP Limited Partnership | 515.41% | 13,773,653 | $2.44M | Insider |
| Erez Chimovits | 173.14% | 4,626,978 | $818.98k | Insider |
| Chidozie Ugwumba | 112.15% | 2,997,025 | $530.47k | Insider |
| James E. Flynn | 93.33% | 2,494,108 | $441.46k | Insider |
| Takeda Pharmaceutical Co Ltd | 92.46% | 2,470,935 | $437.36k | Insider |
| Jonas Grossman | 77.84% | 2,080,217 | $368.20k | Insider |
| Fibrosis Foundation Cystic | 66.90% | 1,787,758 | $316.43k | Insider |
| Gbolahan Amusa | 9.84% | 262,871 | $46.53k | Insider |
| Kerry Propper | 9.76% | 260,771 | $46.16k | Insider |
| Jonathan Eitan Solomon | 4.74% | 126,748 | $22.43k | Insider |
HLSQ vs Biotech Stocks
Tessera Defense & Homeland Security Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.